5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+12.14%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$377M
AUM Growth
+$377M
(+8.5%)
Cap. Flow
+$20.4M
Cap. Flow
% of AUM
5.4%
Top 10 Holdings %
Top 10 Hldgs %
73.32%
Holding
28
New
2
Increased
4
Reduced
2
Closed
3
Top Buys
| 1 |
Biohaven
BHVN
|
$17.1M |
| 2 |
Merus
MRUS
|
$14.3M |
| 3 |
Celldex Therapeutics
CLDX
|
$7.42M |
| 4 |
Pharvaris
PHVS
|
$5.89M |
| 5 |
Viridian Therapeutics
VRDN
|
$3.85M |
Top Sells
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$13.7M |
| 2 |
Disc Medicine
IRON
|
$8.33M |
| 3 |
Arvinas
ARVN
|
$6.28M |
| 4 |
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
|
$1.24M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
$639K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Arvinas
ARVN
$568M
| – | – |
-320,000
| Closed | -$6.28M |
|
|
27
Crinetics Pharmaceuticals
CRNX
$2.92B
| – | – |
-462,286
| Closed | -$13.7M |
|
|
IMPL
28
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| – | – |
-2,884,791
| Closed | -$1.24M |
|